Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
NEW DELHI, Jan 3 (Reuters) - India's drugs regulator said on Sunday it had given final emergency-use approval for two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech. (Reporti...
Read moreBy Sudarshan Varadhan and Krishna N. DasCHENNAI/NEW DELHI, Jan 2 (Reuters) - India's drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZen...
Read moreNEW DELHI, Jan 2 (Reuters) - India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matt...
Read moreMOSCOW, Jan 2 (Reuters) - Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDI...
Read moreNEW DELHI, Jan 2 (Reuters) - Experts at India's drug regulator have recommended emergency-use approval for the AstraZeneca/Oxford vaccine and another developed locally by Bharat Biotech and a state-run research body, the government said on Saturd...
Read moreBy Andrew MacAskillLONDON, Jan 2 (Reuters) - Britain will allow people to be given shots of different COVID-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.In a departure from other st...
Read more
London Schools To Remain Closed As Covid Vaccination Programme Expands
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* Expert team recommends approving Bharat Biotech shotBy Krishna N. DasNEW DELHI, Jan 2 (Reuters) - Experts at India's drugs regulators have...
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* Expert team recommends approving Bharat Biotech shot (Adds possible approval for another vaccine, paragraphs 8-9)By Krishna N. DasNEW DELH...
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* Expert team recommends approving Bharat Biotech shot (Add comments on dosage)By Krishna N. DasNEW DELHI, Jan 2 (Reuters) - Experts at Indi...
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* Expert team recommends approving Bharat Biotech shot (Adds drug regulator to announce details on Sunday)By Krishna N. DasNEW DELHI, Jan 2 ...
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* Expert team recommends approving Bharat Biotech shot (Adds comment on locally-made vaccine)By Krishna N. DasNEW DELHI, Jan 2 (Reuters) - E...
Read more* India aims to vaccinate 300 mln people in 6-8 months* Country has 2nd highest number of COVID-19 infections* SII had applied for 2 full-dose regimen, 28 days apart (Adds details)By Krishna N. DasNEW DELHI, Jan 2 (Reuters) - India has approved the ...
Read more(Adds details)NEW DELHI, Jan 2 (Reuters) - India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country.Information and Broadcas...
Read more(Adds background)Jan 1 (Reuters) - About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the United Kingdom, The Times reported.AstraZeneca expects ...
Read more
Last checked at